You may also like
FDA Advisory Committee Strongly Endorses Use of Trasylol® in CABG Surgery Patients
Bayer was glad to participate in today’s advisory committee meeting held by the Cardiovascular and Renal Drugs Division of the U.S. Food and Drug Administration (FDA). This session provided an open forum in which to discuss the complex scientific issues surrounding the risk/benefit profile of Trasylol® (aprotinin injection) in detail.
1 min read
Extracorporeal Membrane Oxygenation in the Management of Diffuse Alveolar Hemorrhage
We describe our center's experience with 4 patients who received ECMO for refractory hypoxemic respiratory failure due to diffuse alveolar hemorrhage (DAH), a condition for which anticoagulation is typically contraindicated, and provide a review of the literature.
1 min read
Long-term Behavorial Impairment Reported After Neonatal Arterial Switch Surgery
Parents of children who had undergone a neonatal arterial switch operation with circulatory arrest and low flow bypass report that these children […]
1 min read